<p>Aveanna Healthcare Holdings Inc.（NASDAQ:AVAH - 获取免费报告）的股票被十家研究公司一致推荐为 “持有”，Marketbeat Ratings 报告称。六位分析师对该股票给予了持有评级，四位分析师则给予了买入评级。在过去一年中更新了对该股票覆盖的分析师中，平均 12 个月目标价为 10.1875 美元。</p>
<p>最近，一些分析师对该公司发布了报告。瑞银集团将 Aveanna Healthcare 的目标价从 9.00 美元上调至 9.50 美元，并在 11 月 7 日的研究报告中给予该股票 “中性” 评级。加拿大皇家银行在 10 月 24 日的研究报告中将 Aveanna Healthcare 的目标价从 8.00 美元上调至 10.00 美元，并给予该股票 “行业表现” 评级。巴克莱在 8 月 19 日的报告中将 Aveanna Healthcare 的评级从 “持平” 上调至 “超配”，并将该公司的目标价从 5.50 美元上调至 9.50 美元。摩根大通在 9 月 18 日的研究报告中将 Aveanna Healthcare 的评级从 “减持” 上调至 “中性”，并将该公司的目标价从 6.00 美元上调至 10.00 美元。最后，BMO 资本市场在 11 月 13 日的研究报告中开始覆盖 Aveanna Healthcare，并设定了 “跑赢大盘” 的评级和 11.00 美元的目标价。</p>
<p>获取 <strong>Aveanna Healthcare</strong> 的提醒：</p>
<p><strong>查看我们最新的 AVAH 股票报告</strong></p>
<h2>内部买卖</h2>
<p>在其他消息中，主要股东 J.H. Whitney Equity Partners V 在 10 月 21 日的交易中出售了 8,346,059 股公司的股票。股票以平均价格 9.00 美元出售，总价值为 75,114,531.00 美元。出售完成后，该内部人士在公司中持有 20,544,696 股，估值约为 184,902,264 美元。此次交易使其持股减少了 28.89%。该交易在向 SEC 提交的文件中披露，可以通过此超链接访问。此外，主要股东 Paul R. Vigano 在 10 月 21 日的交易中出售了 10,000,000 股 Aveanna Healthcare 的股票。股票以平均价格 9.00 美元出售，总交易额为 90,000,000.00 美元。交易完成后，该内部人士直接持有 386,284 股，估值约为 3,476,556 美元。此次交易使其持股减少了 96.28%。SEC 对此次出售的文件提供了更多信息。内部人士在上个季度共出售了 32,597,968 股公司股票，价值 293,381,712 美元。公司内部人士持有 7.80% 的股票。</p>
<h2>机构资金流入和流出</h2>
<p>一些机构投资者和对冲基金最近调整了对该公司的持股。Summit Partners L P 在第二季度收购了 Aveanna Healthcare 的新股份，价值约为 50,477,000 美元。AustralianSuper Pty Ltd 在第三季度收购了 Aveanna Healthcare 的股份，价值约为 15,743,000 美元。先锋集团在第三季度将其在 Aveanna Healthcare 的股份增加了 34.7%。先锋集团现在持有 4,041,659 股公司的股票，价值为 35,850,000 美元，此前在该期间内又收购了 1,041,324 股。Hillsdale Investment Management Inc.在第三季度收购了 Aveanna Healthcare 的新股份，价值约为 7,922,000 美元。最后，Assenagon Asset Management S.A.在第三季度收购了 Aveanna Healthcare 的股份，价值约为 7,356,000 美元。对冲基金和其他机构投资者持有公司 87.96% 的股票。</p>
<h2>Aveanna Healthcare 股票表现</h2>
<p>NASDAQ:AVAH 的股票在周五开盘价为 9.32 美元。该公司的 50 日简单移动平均为 9.03 美元，200 日简单移动平均为 6.90 美元。公司的速动比率为 1.23，流动比率为 1.23，债务与股本比率为 140.39。该股票的市值为 19.5 亿美元，市盈率为 25.88，贝塔值为 2.04。Aveanna Healthcare 的 52 周最低价为 3.67 美元，52 周最高价为 10.32 美元。</p>
<p>Aveanna Healthcare（NASDAQ:AVAH - 获取免费报告）最后一次公布季度财报是在 5 月 22 日，报告显示该季度每股收益为 0.04 美元。该公司在该季度的收入为 4.5053 亿美元。Aveanna Healthcare 的净利润率为 3.29%，股本回报率为负的 143.55%。分析师平均预计 Aveanna Healthcare 在当前财年将发布-0.06 的每股收益。</p>
<h2>Aveanna Healthcare 公司简介</h2>
<p>（获取免费报告）</p>
<p>Aveanna Healthcare Holdings Inc 是一家多元化的居家护理平台公司，在美国提供儿科和成人医疗服务。其以患者为中心的护理交付平台使患者能够留在家中，减少高成本护理环境（如医院或专业护理机构）的过度使用。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票，而不是 Aveanna Healthcare</li>
<li>什么是股票市场指数，如何使用它们？</li>
<li>开启：Applied Digital 的首个 AI 数据中心上线</li>
<li>ETF 支付股息吗？你需要知道的事项</li>
<li>Alphabet：最有可能主导 2026 年的 AI 领导者</li>
<li>3 只防御类股票将受益于军事支出增加</li>
<li>2 个理由让你加仓 Fiserv，1 个理由让你远离</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVZBSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVZBSA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Aveanna Healthcare 吗？</h2>
<p>在考虑 Aveanna Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Aveanna Healthcare 并不在名单上。</p>
<p>虽然 Aveanna Healthcare 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

AVAH

<p>Aveanna Healthcare Holdings Inc.（纳斯达克代码：AVAH）获得了十家研究公司的共识 “持有” 评级。分析师设定的 12 个月平均目标价为 10.1875 美元。最近的分析师行动包括瑞银集团将目标价上调至 9.50 美元，加拿大皇家银行上调至 10.00 美元，巴克莱将评级上调至 “增持”，目标价为 9.50 美元，摩根大通将评级上调至 “中性”，目标价为 10.00 美元。此外，内部销售和机构投资也受到关注，主要股东进行了显著的股票交易</p>

<p>Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) have been assigned a consensus recommendation of &#34;Hold&#34; from the ten research firms that are covering the stock, Marketbeat Ratings reports. Six analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $10.1875.</p>
<div class="lb-trans"><p>Aveanna Healthcare Holdings Inc.（NASDAQ:AVAH - 获取免费报告）的股票被十家研究公司一致推荐为 “持有”，Marketbeat Ratings 报告称。六位分析师对该股票给予了持有评级，四位分析师则给予了买入评级。在过去一年中更新了对该股票覆盖的分析师中，平均 12 个月目标价为 10.1875 美元。</p>
</div><p>A number of analysts recently issued reports on the company. UBS Group raised their price target on Aveanna Healthcare from $9.00 to $9.50 and gave the stock a &#34;neutral&#34; rating in a research report on Friday, November 7th. Royal Bank Of Canada lifted their price target on shares of Aveanna Healthcare from $8.00 to $10.00 and gave the stock a &#34;sector perform&#34; rating in a research note on Friday, October 24th. Barclays upgraded shares of Aveanna Healthcare from an &#34;equal weight&#34; rating to an &#34;overweight&#34; rating and upped their price target for the company from $5.50 to $9.50 in a report on Tuesday, August 19th. JPMorgan Chase &amp; Co. raised Aveanna Healthcare from an &#34;underweight&#34; rating to a &#34;neutral&#34; rating and upped their target price for the company from $6.00 to $10.00 in a research note on Thursday, September 18th. Finally, BMO Capital Markets began coverage on Aveanna Healthcare in a research report on Thursday, November 13th. They set an &#34;outperform&#34; rating and a $11.00 target price for the company.</p>
<div class="lb-trans"><p>最近，一些分析师对该公司发布了报告。瑞银集团将 Aveanna Healthcare 的目标价从 9.00 美元上调至 9.50 美元，并在 11 月 7 日的研究报告中给予该股票 “中性” 评级。加拿大皇家银行在 10 月 24 日的研究报告中将 Aveanna Healthcare 的目标价从 8.00 美元上调至 10.00 美元，并给予该股票 “行业表现” 评级。巴克莱在 8 月 19 日的报告中将 Aveanna Healthcare 的评级从 “持平” 上调至 “超配”，并将该公司的目标价从 5.50 美元上调至 9.50 美元。摩根大通在 9 月 18 日的研究报告中将 Aveanna Healthcare 的评级从 “减持” 上调至 “中性”，并将该公司的目标价从 6.00 美元上调至 10.00 美元。最后，BMO 资本市场在 11 月 13 日的研究报告中开始覆盖 Aveanna Healthcare，并设定了 “跑赢大盘” 的评级和 11.00 美元的目标价。</p>
</div><p>Get <strong>Aveanna Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Aveanna Healthcare</strong> 的提醒：</p>
</div><p><strong>Check Out Our Latest Stock Report on AVAH</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 AVAH 股票报告</strong></p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖</h2>
</div><p>In other news, major shareholder J.H. Whitney Equity Partners V sold 8,346,059 shares of the business's stock in a transaction dated Tuesday, October 21st. The shares were sold at an average price of $9.00, for a total value of $75,114,531.00. Following the completion of the sale, the insider owned 20,544,696 shares in the company, valued at approximately $184,902,264. The trade was a 28.89% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder Paul R. Vigano sold 10,000,000 shares of Aveanna Healthcare stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of $9.00, for a total transaction of $90,000,000.00. Following the transaction, the insider directly owned 386,284 shares in the company, valued at approximately $3,476,556. The trade was a 96.28% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 32,597,968 shares of company stock valued at $293,381,712 over the last quarter. 7.80% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他消息中，主要股东 J.H. Whitney Equity Partners V 在 10 月 21 日的交易中出售了 8,346,059 股公司的股票。股票以平均价格 9.00 美元出售，总价值为 75,114,531.00 美元。出售完成后，该内部人士在公司中持有 20,544,696 股，估值约为 184,902,264 美元。此次交易使其持股减少了 28.89%。该交易在向 SEC 提交的文件中披露，可以通过此超链接访问。此外，主要股东 Paul R. Vigano 在 10 月 21 日的交易中出售了 10,000,000 股 Aveanna Healthcare 的股票。股票以平均价格 9.00 美元出售，总交易额为 90,000,000.00 美元。交易完成后，该内部人士直接持有 386,284 股，估值约为 3,476,556 美元。此次交易使其持股减少了 96.28%。SEC 对此次出售的文件提供了更多信息。内部人士在上个季度共出售了 32,597,968 股公司股票，价值 293,381,712 美元。公司内部人士持有 7.80% 的股票。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of institutional investors and hedge funds have recently modified their holdings of the company. Summit Partners L P acquired a new stake in Aveanna Healthcare in the second quarter worth about $50,477,000. AustralianSuper Pty Ltd acquired a new stake in shares of Aveanna Healthcare during the third quarter worth about $15,743,000. Vanguard Group Inc. increased its stake in shares of Aveanna Healthcare by 34.7% in the third quarter. Vanguard Group Inc. now owns 4,041,659 shares of the company's stock worth $35,850,000 after acquiring an additional 1,041,324 shares during the period. Hillsdale Investment Management Inc. acquired a new stake in Aveanna Healthcare during the 3rd quarter worth about $7,922,000. Finally, Assenagon Asset Management S.A. purchased a new stake in shares of Aveanna Healthcare in the third quarter worth about $7,356,000. Hedge funds and other institutional investors own 87.96% of the company's stock.</p>
<div class="lb-trans"><p>一些机构投资者和对冲基金最近调整了对该公司的持股。Summit Partners L P 在第二季度收购了 Aveanna Healthcare 的新股份，价值约为 50,477,000 美元。AustralianSuper Pty Ltd 在第三季度收购了 Aveanna Healthcare 的股份，价值约为 15,743,000 美元。先锋集团在第三季度将其在 Aveanna Healthcare 的股份增加了 34.7%。先锋集团现在持有 4,041,659 股公司的股票，价值为 35,850,000 美元，此前在该期间内又收购了 1,041,324 股。Hillsdale Investment Management Inc.在第三季度收购了 Aveanna Healthcare 的新股份，价值约为 7,922,000 美元。最后，Assenagon Asset Management S.A.在第三季度收购了 Aveanna Healthcare 的股份，价值约为 7,356,000 美元。对冲基金和其他机构投资者持有公司 87.96% 的股票。</p>
</div><h2>Aveanna Healthcare Stock Performance</h2>
<div class="lb-trans"><h2>Aveanna Healthcare 股票表现</h2>
</div><p>Shares of NASDAQ:AVAH opened at $9.32 on Friday. The firm has a fifty day simple moving average of $9.03 and a two-hundred day simple moving average of $6.90. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39. The stock has a market capitalization of $1.95 billion, a P/E ratio of 25.88 and a beta of 2.04. Aveanna Healthcare has a 52 week low of $3.67 and a 52 week high of $10.32.</p>
<div class="lb-trans"><p>NASDAQ:AVAH 的股票在周五开盘价为 9.32 美元。该公司的 50 日简单移动平均为 9.03 美元，200 日简单移动平均为 6.90 美元。公司的速动比率为 1.23，流动比率为 1.23，债务与股本比率为 140.39。该股票的市值为 19.5 亿美元，市盈率为 25.88，贝塔值为 2.04。Aveanna Healthcare 的 52 周最低价为 3.67 美元，52 周最高价为 10.32 美元。</p>
</div><p>Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last announced its quarterly earnings results on Monday, May 22nd. The company reported $0.04 EPS for the quarter. The firm had revenue of $450.53 million during the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. On average, analysts expect that Aveanna Healthcare will post -0.06 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Aveanna Healthcare（NASDAQ:AVAH - 获取免费报告）最后一次公布季度财报是在 5 月 22 日，报告显示该季度每股收益为 0.04 美元。该公司在该季度的收入为 4.5053 亿美元。Aveanna Healthcare 的净利润率为 3.29%，股本回报率为负的 143.55%。分析师平均预计 Aveanna Healthcare 在当前财年将发布-0.06 的每股收益。</p>
</div><h2>Aveanna Healthcare Company Profile</h2>
<div class="lb-trans"><h2>Aveanna Healthcare 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.</p>
<div class="lb-trans"><p>Aveanna Healthcare Holdings Inc 是一家多元化的居家护理平台公司，在美国提供儿科和成人医疗服务。其以患者为中心的护理交付平台使患者能够留在家中，减少高成本护理环境（如医院或专业护理机构）的过度使用。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Aveanna Healthcare</li>
<li>What is a Stock Market Index and How Do You Use Them?</li>
<li>Power On: Applied Digital’s First AI Data Center Goes Live</li>
<li>Do ETFs Pay Dividends? What You Need to Know</li>
<li>Alphabet: The AI Leader Best Positioned to Dominate 2026</li>
<li>3 Defense Stocks Set to Benefit From Increased Military Spending</li>
<li>2 Reasons to Load Up on Fiserv, 1 to Stay Away</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是 Aveanna Healthcare</li>
<li>什么是股票市场指数，如何使用它们？</li>
<li>开启：Applied Digital 的首个 AI 数据中心上线</li>
<li>ETF 支付股息吗？你需要知道的事项</li>
<li>Alphabet：最有可能主导 2026 年的 AI 领导者</li>
<li>3 只防御类股票将受益于军事支出增加</li>
<li>2 个理由让你加仓 Fiserv，1 个理由让你远离</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVZBSA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=AVAH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Aveanna Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Aveanna Healthcare 吗？</h2>
</div><p>Before you consider Aveanna Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Aveanna Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Aveanna Healthcare 并不在名单上。</p>
</div><p>While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Aveanna Healthcare 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) 被分析师给予平均 “持有” 评级